Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0002007191-25-000061
Filing Date
2025-07-22
Accepted
2025-07-22 08:25:21
Documents
3
Period of Report
2025-07-22

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS q2bizupdate.htm 6-K 11284
2 EX-99.1 q2pr.htm EX-99.1 50343
3 image1.gif GRAPHIC 35096
  Complete submission text file 0002007191-25-000061.txt   111111
Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051
Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855
Telix Pharmaceuticals Ltd (Filer) CIK: 0002007191 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42128 | Film No.: 251138746
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)